Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $524.68 | 22 | 83.2% |
| Education | $105.91 | 2 | 16.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $292.74 | 10 | $0 (2024) |
| GENZYME CORPORATION | $121.74 | 5 | $0 (2023) |
| Integra LifeSciences Corporation | $86.86 | 3 | $0 (2024) |
| Optinose US, Inc. | $38.45 | 2 | $0 (2021) |
| Acclarent, Inc | $35.17 | 1 | $0 (2024) |
| Merck Sharp & Dohme LLC | $22.58 | 1 | $0 (2023) |
| GlaxoSmithKline, LLC. | $17.94 | 1 | $0 (2024) |
| Medtronic, Inc. | $15.11 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $221.30 | 8 | Regeneron Healthcare Solutions, Inc. ($95.01) |
| 2023 | $293.88 | 10 | Regeneron Healthcare Solutions, Inc. ($168.51) |
| 2022 | $44.33 | 2 | Regeneron Healthcare Solutions, Inc. ($29.22) |
| 2021 | $54.51 | 3 | Optinose US, Inc. ($21.88) |
| 2019 | $16.57 | 1 | OptiNose US, Inc. ($16.57) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.83 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/19/2024 | Integra LifeSciences Corporation | ACCLARENT AERA (Device), INSPIRA AIR, RELIEVA SPINPLUS NAV | Food and Beverage | In-kind items and services | $44.43 | General |
| Category: ENT | ||||||
| 05/01/2024 | Integra LifeSciences Corporation | ACCLARENT AERA (Device), INSPIRA AIR, RELIEVA SPINPLUS NAV | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: ENT | ||||||
| 04/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/07/2024 | Acclarent, Inc | RELIEVA SPINPLUS (Device) | Food and Beverage | In-kind items and services | $35.17 | General |
| Category: Rhinology | ||||||
| 01/31/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/31/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $17.71 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/25/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.74 | General |
| Category: Immunology | ||||||
| 10/18/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $22.58 | General |
| 08/23/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/02/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Immunology | ||||||
| 06/28/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/24/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.01 | General |
| Category: Immunology | ||||||
| 04/19/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/01/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: Immunology | ||||||
| 02/01/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $88.20 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/13/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.22 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/06/2022 | Medtronic, Inc. | PROPEL (Device) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/15/2021 | Integra LifeSciences Corporation | INTEGRA DUO (Device), INTEGRA PADGETT DERMATOMES | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: PRECISION TOOLS & INSTRUMENTS | ||||||
| 11/15/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Immunology | ||||||
| 09/13/2021 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 02/28/2019 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,044 | 2,064 | $248,509 | $90,347 |
| 2022 | 12 | 1,070 | 2,143 | $274,628 | $97,747 |
| 2021 | 12 | 807 | 1,043 | $198,199 | $74,671 |
| 2020 | 12 | 620 | 791 | $137,545 | $46,119 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 248 | 317 | $56,677 | $21,082 | 37.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 137 | 162 | $41,014 | $15,326 | 37.4% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 225 | 334 | $32,079 | $11,724 | 36.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 96 | 96 | $31,910 | $11,082 | 34.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 117 | 117 | $26,216 | $8,850 | 33.8% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 42 | 52 | $19,384 | $7,110 | 36.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 101 | 156 | $17,444 | $6,571 | 37.7% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 57 | 69 | $17,697 | $6,524 | 36.9% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 21 | 761 | $6,088 | $2,077 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 157 | 192 | $49,158 | $18,733 | 38.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 217 | 271 | $49,323 | $18,576 | 37.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 130 | 130 | $43,940 | $15,682 | 35.7% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 63 | 71 | $26,860 | $10,498 | 39.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 110 | 110 | $24,969 | $8,720 | 34.9% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 172 | 244 | $32,254 | $8,273 | 25.6% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 69 | 79 | $20,461 | $7,814 | 38.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 85 | 125 | $14,248 | $4,824 | 33.9% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 24 | 876 | $7,884 | $2,882 | 36.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 17 | 17 | $2,499 | $780.98 | 31.3% |
| 95992 | Repositioning exercises of head for treatment of dizziness, each day | Office | 2022 | 14 | 16 | $1,408 | $557.30 | 39.6% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2022 | 12 | 12 | $1,624 | $404.84 | 24.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 119 | 159 | $41,181 | $15,935 | 38.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 135 | 179 | $32,757 | $12,739 | 38.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 82 | 82 | $27,716 | $10,625 | 38.3% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 135 | 196 | $21,172 | $7,082 | 33.4% |
About Dr. Paula Pyle, MD
Dr. Paula Pyle, MD is a Pediatric Otolaryngology healthcare provider based in Venice, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043290950.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paula Pyle, MD has received a total of $630.59 in payments from pharmaceutical and medical device companies, with $221.30 received in 2024. These payments were reported across 24 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($524.68).
As a Medicare-enrolled provider, Pyle has provided services to 3,541 Medicare beneficiaries, totaling 6,041 services with total Medicare billing of $308,883. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Pediatric Otolaryngology
- Other Specialties Otolaryngology
- Location Venice, FL
- Active Since 01/18/2006
- Last Updated 10/28/2021
- Taxonomy Code 207YP0228X
- Entity Type Individual
- NPI Number 1043290950
Products in Payments
- DUPIXENT (Biological) $414.48
- ACCLARENT AERA (Device) $73.18
- Xhance (Drug) $38.45
- RELIEVA SPINPLUS (Device) $35.17
- NUCALA (Biological) $17.94
- PROPEL (Device) $15.11
- INTEGRA DUO (Device) $13.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.